Endovascular Therapy Demonstrates Benefit Over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale
Interventional Neurology - Switzerland
doi 10.1159/000452137
Full Text
Open PDFAbstract
Available in full text
Date
October 19, 2016
Authors
Publisher
S. Karger AG